An access to cutting-edge protocols and tools for patients
Patients with severe diabetes resisting to conventional treatments need “exceptional” means to control the disease, permanently or for a short period of time corresponding to acute life-threatening conditions (e.g. infections, after surgery, during cancer chemotherapy). PreciDIAB will offer world class access to cutting-edge protocols and tools: artificial pancreas, and optimized pancreatic islet transplantation. In addition, PreciDIAB unique diabetes Clinical Trial Unit will enrol the most challenging patients in clinical trials of innovative drugs (developed by PreciDIAB teams or by drug companies).